RxDoctor Payments Data

Ashley Hall

Adult Health · Lebanon, TNNPI 1366733396

Payments from drug & device makers

$2,428in general payments, 2019–2025

Across 114 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$601
  • Abbott$537
  • Astellas Pharma US Inc$161
  • AbbVie$149
  • Ferring Pharmaceuticals Inc.$138
  • Daiichi Sankyo Inc.$107
  • plus $736 from 13 others

What the payments were for

  • Food & beverage$2,34396%
  • Education$854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,428 in reported general payments places this provider in the 80th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee

Medicare billing

Part B allowed, 2024
$25,578
Medicare patients
99
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,511
BelsomraSuvorexant22$9,233
LinzessLinaclotide12$8,058
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen67$2,810
Gabapentin130$2,755
Oxycodone Hcl73$1,510
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$1,238
Alprazolam101$740
ValacyclovirValacyclovir Hcl17$680
Pregabalin42$637
Cefdinir32$587
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$450
Amlodipine Besylate24$444
Duloxetine Hcl27$439
Memantine Hcl12$402

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$91$12,51119 claims
MerckBelsomra$14$9,23322 claims
AbbVieLinzess$149$8,05812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 352 adult health providers in Tennessee.

Other adult health in Lebanon

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →